论文部分内容阅读
2009年2月3日Tibotec制药公司宣布,欧盟委员会已经批准每日一次用药(剂量为800mg)的达芦那韦(darunavir)片剂与低剂量利托那韦(ritonavir)联合用药用于初治HIV-1成人感染者。
February 3, 2009 Tibotec Pharmaceuticals announces that the European Commission has approved darunavir tablets in combination with low-dose ritonavir once daily (800 mg) for initial treatment HIV-1 adult infection.